CrossrefInfokarte
Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review
Journal of Hematology · 2026-10 · 15 (5) · 219-224
DOI: 10.14740/jh2233 ↗Abstract
Kein Abstract verfügbar.
EUVIMED